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Background: Xanthogranulomatous inflammation is an uncommon form of chronic inflammation that is
destructive to the normal tissue of affected organs. Although xanthogranulomatous endometritis and
xanthogranulomatous salpingitis of the female genital tract has been described previously, to the best of our
knowledge, this is the first report of xanthogranulomatous inflammation with infiltration into the uterine
myometrium from the perimetrium without endometritis.
Case presentation: A 68-year-old Japanese woman with intermittent lower abdominal pain and low-grade fever
who was initially treated with antibiotics underwent hysterectomy due to abscess formation in the posterior wall of
the myometrium and perimetrium (the outer serosal layer of the uterus). Histopathological findings revealed that the
abscess was caused by xanthogranulomatous inflammation with the granulation tissue and chronic inflammatory
cells that consisted of focal and sheets of foam cells. The inflammation destroyed the perimetrial elastic lamina, and the
myometrium was deeply infiltrated by the xanthoma cells. Neither endometritis nor salpingitis was coexistent with the
xanthogranulomatous inflammation.
Conclusion: The patient was diagnosed as xanthogranulomatous inflammation, most likely arising from the
perimetrium. Our findings suggest that the perimetrium, as well as the endometrium and adnexae, is one of the origins
of xanthogranulomatous inflammation in female genital tract.
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Xanthogranulomatous inflammation (XGI) is an un-
common form of chronic inflammation that may destruct
the normal tissue of affected organs. Histopathologically, it is
characterized by a marked proliferative fibrosis, parenchymal
destruction, and infiltration of foamy histiocytes intermixed
with other inflammatory cells.
XGI has been reported in multiple organs, most
commonly in the kidney and gall bladder, and less com-
monly in the female genital tract [1,2]. XGI in the female* Correspondence: katsutoshi-tky@umin.ac.jp
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and/or salpingitis (tubo-ovarian abscess) [3-12]; XGI with
uterine myometritis but without endometritis has not
been reported. Herein, we report a case of a 68-year-old
woman diagnosed with XGI with myometritis, in whom
the histopathological findings revealed that XGI was
located only in the myometrium and perimetrium, without
affecting the endometrium.Case presentation
A 68-year-old (gravida 4, para 2) post-menopausal woman
presented to our hospital with vaginal bleeding. She had a
history of multiple uterine fibroids over the past 20 years,
but no history of endometriosis, pelvic inflammatorytd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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family history was unremarkable.
Ultrasonography revealed no abnormal masses except
for multiple uterine fibroids. Cytoscreening of the cervix
and endometrium was performed. One week later, the
patient presented to our hospital with a fever (up to 39°C)
and abdominal pain. Escherichia coli was detected in her
vaginal culture. She was diagnosed with endometritis and
treated with antibiotics (levofloxacin). In addition, the cy-
tology of the endometrium showed atypical columnar cells
with inflammation, for which further examination was rec-
ommended to rule out malignancy. After her symptoms
improved, endometrial biopsy was performed under levo-
floxacin. Pathologically, inflamed endocervical mucosa and
endometrium were observed, but no malignant cells were
detected. The white blood cell count was 8.3 × 103/uL. Six
weeks later, she visited our hospital again due to persistent
low-grade fever and abdominal pain. Transvaginal ultra-
sonography revealed an irregularly shaped mass, 6 cm in
diameter, in the posterior wall of the myometrium.
Contrast-enhanced computed tomography (CT) scan sug-
gested an intramural abscess besides multiple uterine fi-
broids. Magnetic resonance imaging (MRI) also revealed
an irregularly shaped mass, 6 cm in diameter, which was
localized in the posterior wall of the uterus (Figure 1A and
B). On T2-weighted MRI, the perimetrium of the posterior
wall was revealed to be edematous with suspected adhe-
sions to the sigmoid colon and rectum. The white bloodA
B
Figure 1 Magnetic resonance imaging (MRI) and photographs during
high-intensity by sagittal T2-weighted (A) and low-intensity by sagittal T1-wei
imaging (B), located in the posterior myometrium. (C, D) Intra-pelvic adhesion
wall of the uterus (C) and sigmoid colon (D).cell count and C-reactive protein (CRP) were elevated to
20.2 × 103/uL and 14.6 mg/dL, respectively.
Total abdominal hysterectomy and bilateral salpingo-
oophorectomy were performed. The uterus was enlarged
due to the uterine fibroids and abscess, and dense adhe-
sions existed around the posterior wall of the uterus and
sigmoid colon (Figure 1C and D). There was neither
inflammation nor enlargement in the bilateral adnexae.
The postoperative course was uneventful, and the patient
was discharged 8 days after the surgery. An endoscopic
examination of the rectum and colon showed no evidence
of diverticulum and malignancy.
Macroscopically, an abscess, 6 cm in diameter, was
present in the posterior perimetrium (Figure 2A). The cut
surface of the abscess was purulent with hemorrhage,
necrosis, and cystic degeneration, and was apart from the
endometrium (Figure 2B). Microscopically, marked in-
filtration of foamy histiocytes with clear lipid-containing
cytoplasm, together with abundant lymphocytes and
plasma cells, was observed in the posterior uterine myo-
metrium. The infiltration destroyed the perimetrial elastic
lamina and the myometrium was deeply infiltrated by the
granulation tissue and chronic inflammatory cells with
focal or sheets of foam cells (xanthoma cells) (Figure 2C
and D). Neutrophils were also observed at the posterior
wall surrounding the abscess cavity. These findings were
consistent with XGI of the uterine corpus. However, there
were no xanthoma cells in the endometrium and bilateralC
D
surgery. MRI findings of a 6 cm mass in diameter (arrow) with
ghted (fat-suppressed) imaging, combined with gadolinium-enhanced
s secondary to perimetrial inflammation. Adhesions around the posterior
A B
C D
Figure 2 Macroscopic and microscopic features of the abscess. (A) Photograph of the excised uterus. The endometrium was smooth with
no inflammatory changes (left), and the abscess was located in the posterior wall of the uterus (right). (B) Photograph of the cut surface of the
uterus. The posterior myometrium and perimetrium were yellowish and with areas of necrosis and hemorrhage. (C) Microscopic features (low
power): The inflammation destroyed the perimetrium, infiltrated deep into the myometrium (left) but did not reach the endometrium (right).
(D) Microscopic features (low power): The xanthogranulomatous inflammation with foamy histiocytes and neutrophils, infiltrating into the
myometrium. The smooth muscle cells were dispersed diffusely among the inflammatory cells.
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from the perimetrium and infiltrating deep into the
posterior uterine myometrium.
Discussion
XGI is a rare inflammatory disease, which may affect vari-
ous organs, including the kidney and gallbladder [1,2].
XGI is a severe inflammation and might be lethal in some
cases [7]. So far, all reported XGI cases involving the fe-
male genital tract have been of endometritis and salpin-
gitis [3-12]. As the perimetrium has not been previously
reported as the origin of XGI, making a diagnosis in this
case required careful consideration. Although inflamma-
tion did not affect the endometrium and adnexae, it is still
possible that XGI from previously experienced endometri-
tis infiltrated from the endometrium to the uterine myo-
metrium and perimetrium. Indeed, her first endometrialcytology and biopsy indicated inflamed endometrial cells.
In addition, it is difficult to exclude the possibility that
the sigmoid colon may be an origin of XGI because
antibiotics had been administered before the hysterec-
tomy. However, the microscopic spread pattern of XGI
in this case suggests that the origin is more likely to be
the perimetrium rather than the endometrium, fallopian
tubes, or sigmoid colon.
One of the primary differential diagnosis of XGI is
malignancy [8,13]. Indeed, endometrial hyperplasia and
endometrial carcinomas have been detected in patients
with XGI with endometritis [14]. Therefore, cytological
and histological diagnosis is important to rule out endo-
metrial cancer in XGI cases. Although it is not clear
whether the initial inflammation in the endometrium
was associated with the abscess formation, the XGI
might be affected by intrauterine examination in this
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of XGI in the genital tract.
Conclusion
Here, we have reported a case of severe XGI, originating
from the perimetrium into the deep posterior uterine myo-
metrium. Our case highlights the need for careful assess-
ment of the inflammatory diseases in female genital tract.
Pelvic inflammatory diseases are commonly associated with
sexually transmitted diseases, intrauterine devices, or previ-
ously experienced surgeries, and the inflammations com-
monly originate from the adnexae and the endometrium.
However, our case indicated that the inflammation of the
perimetrium might deeply infiltrate into the myometrium
and cause dense adhesion with the colorectum. Thus,
careful considerations are warranted to diagnose the origin
of the inflammatory diseases and to appropriately treat the
diseases in the female genital tract.
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